The Adverse Outcome Pathway (AOP) framework describes the progression of a toxicity pathway from molecular perturbation to population-level outcome in a series of measurable, mechanistic responses. The controlled, computer-readable vocabulary that defines an AOP has the ability to, automatically and on a large scale, integrate AOP knowledge with publically available sources of biological high-throughput data and its derived associations. To support the discovery and development of putative (existing) and potential AOPs, we introduce the AOP-DB, an exploratory database resource that aggregates association relationships between genes and their related chemicals, diseases, pathways, species orthology information, ontologies, and gene interactions. These associations are mined from publically available annotation databases and are integrated with the AOP information centralized in the AOP-Wiki, allowing for the automatic characterization of both putative and potential AOPs in the context of multiple areas of biological information, referred to here as "biological entities". The AOP-DB acts as a hypothesis-generation tool for the expansion of putative AOPs, as well as the characterization of potential AOPs, through the creation of association networks across these biological entities. Finally, the AOP-DB provides a useful interface between the AOP framework and existing chemical screening and prioritization efforts by the US Environmental Protection Agency.
Introduction
Efforts to inform toxicological risk assessment through the organization of biological information has led to the development of several pathway frameworks, such as the International Program on Chemical Safety mode-of-action (MOA) framework, and the National Research Council's established toxicity pathway framework (Boobis et al., 2006; Boobis et al., 2008; Gibb, 2008) . Most recently, the Organization for Economic Co-operation and Development (OECD) has refined the concept of the adverse outcome pathway (AOP), a chemically agnostic framework that describes existing knowledge of biological perturbation in discrete steps across multiple scales of organization (Ankley et al., 2010; OECD, 2012 ). An AOP follows the events of a toxicity pathway in measurable mechanistic steps, beginning with a Molecular Initiating Event (MIE) that describes an action on a specific biomolecule, through a series of causally-linked Key Events (KE) representing downstream effects at the levels of molecular, cellular, tissue, organ, individual and population-level response, leading to some Adverse Outcome (AO).
To maximize the utility of the AOP construct, aggregation and standardized organization of AOP knowledge is essential. The OECD has developed a series of tools collectively known as the AOP Knowledge Base (AOP-KB) to provide a standardized, systematic structure for AOP development and knowledge dissemination. One such tool, the AOP-Wiki (www.aopwiki.org), facilitates collaborative AOP development by collecting and linking expert-curated AOP information through a controlled vocabulary . This article introduces another tool for the development of AOPs: the AOP-DB is a database resource that relates the information stored in the AOP-Wiki to diseases, chemical-gene associations, taxonomic information, and other biological entities. These associations are sourced from public annotation and provide a wider context of relevant biology for each AOP, thus enabling researchers to expand predictions of chemical stressors and toxicological outcomes.
The AOP framework has already shown strong potential in toxicological chemical assessment, especially as a tool for the prioritization of chemicals, tissues, and organisms for effective assay design and the development of predictive toxicology models (OECD, 2012; Tollefsen et al., 2014) . For example, the AOP can provide a basis for establishing structure-activity relationships between MIE molecular targets and specific xenobiotics of interest (Browne et al., 2015; Landesmann et al., 2012; Vinken et al., 2013) . The identification of intermediate KEs can help identify biologically relevant in vitro assay endpoints (Vinken, 2013) . Further, an established range of susceptible species gives context for regulatory decisions. Workflows to computationally predict taxonomic applicability for MIEs (LaLone et al., 2016) and AOPs (Mortensen, 2017; Mortensen, Pittman et al. in prep) have been described to predict species susceptibility and inform chemical evaluation.
There is a wealth of free, publically available biological information on the web, including "omics" data, high throughput assays, and experimental and inferred associations between biological entities. However, the utility of this abundant knowledge is compromised by its vast dispersion over multiple formats and databases, requiring manipulation and extensive quality control to incorporate usable information. Multiple attempts have been made to integrate these resources in order to improve knowledge discovery, fill complementary information gaps, aid in data interpretation, and allow for collective mining of heterogeneous data types for a more comprehensive view of biological questions (Gligorijevic and Przulj, 2015; Gomez-Cabrero et al., 2014; Judson et al., 2008; Lapatas et al., 2015; Sherman et al., 2007; Smith et al., 2007; Wang et al., 2011) . Integration of publically available data with the AOP framework has been explored for its utility in predicting and developing AOPs (Oki et al., 2016) .
To address the need for an automated system to relate AOPs to useful public information, we introduce the AOP-DB, a database resource that stores preliminary AOP-associated gene targets from the AOP-Wiki and relevant chemicals, diseases, biological pathways, taxonomy, and ontologies. The AOP-DB is a novel resource that integrates multiple heterogeneous data sources and types in a single centralized location, and automatically relates AOP mechanistic information to functional biological entities. The AOP-DB facilitates exploration across multiple levels of biological organization, and species-level variation. To enable the exchange of information among regulatory research efforts, the AOP-DB also interfaces between OECD AOP Discovery and Development tools, as well as other EPA toxicology resources including ToxCast data (Dix et al., 2007) and the EPA Chemistry Dashboards (Richard and Williams, 2002) . The AOP-DB seeks to capture the relationships between these diverse data types in order to profile AOPs in a systems biology context, act as a hypothesis-generation tool for assay development, and aid in the discovery of unidentified AOPs. This paper briefly outlines the design and data sources of the AOP-DB, and illustrates the utility of the tool through three use cases: 1) characterizing the biological space of a putative AOP; 2) exploring the biological overlap between a collection of interconnected AOPs; and 3) hypothesis generation for the development of a potential AOP (e.g. an AOP not yet described). Here we illustrate the AOP-DB's potential as a data integration tool for the characterization of AOPs, as well as a useful interface between OECD and EPA toxicology efforts and the wider landscape of publically available annotation. Though the AOP-DB is not currently available for public download, DB-sourced relationships between AOPs, KEs, chemical stressors, and ToxCast assays are integrated into the EPA Chemistry Dashboard (https://comptox.epa.gov/ dashboard). Other database components are available upon request.
Materials and methods

AOP-DB structure and quality validation
The goal of the AOP-DB is to capture relationships among multiple biological entities to characterize AOP activity in a variety of contexts, such as associated diseases, chemicals, pathways, taxonomic groups, and protein interactions. The AOP-DB was developed on the SQL InnoDB platform version 5.6.36 (Oracle, 2000 (Oracle, -2013 and contains sixteen information tables linked through the centrally located gene identifier table, described below, and in Table 1 and Supplemental Of these total 164 AOPs, it is important to note that 113 are still considered "Under Development" by the OECD, and may be subject to change before they are formally endorsed.
Gene
The AOP-DB's central linking entities are Entrez genes. The Entrez Gene database curated by the National Center for Biotechnology Information (NCBI) is made up of a set of unique identifiers for genes and corresponding gene-specific information, such as taxonomy, protein products, sequences, and orthologs (Maglott, Ostell, Pruitt, & Tatusova, 2011) . These Entrez genes are sourced from fully-sequenced genomes of well-researched organisms. The AOP-DB hosts 1.68 million unique Entrez gene IDs to capture relationships between biological entities.
Entrez gene is not the only identification system for genes and proteins, and data sources occasionally use non-Entrez gene IDs. To ensure that the AOP-DB is capable of using these data as well, a built-in table is included for the mapping of alternative gene IDs to Entrez, curated by the Universal Protein Resource (UniProt, 2015).
Pathway
Biological pathways represent the series of molecular and genetic interactions that amount to the execution of a biological process. The AOP-DB makes use of three sources of pathway information: the Kyoto Encyclopedia of Genes and Genomes (KEGG), a database resource for the functional annotation and network organization of genes, accessed using the REST API (Kanehisa, Furumichi, Tanabe, Sato, & Morishima, 2017) ; Reactome, a database resource containing manually-curated pathway interactions sourced from PubMed literature (Croft et al., 2014) ; and Consensus PathDB, a composite database containing functional interaction data from 32 sources for human, mouse, and yeast pathways (Kamburov, Wierling, Lehrach, & Herwig, 2009) . For each of these sources, pathways and their participating genes were downloaded and stored in the AOP-DB, along with out-links to pathway visualizations where possible. The AOP-DB hosts 75,830 unique pathway IDs, with 3.7 million gene-pathway associations.
Chemical
The AOP-DB stores chemical-gene associations sourced from the Comparative Toxicogenomics Database (CTD), a resource that manually curates and infers relationships between genes, chemicals, and diseases from scientific literature (Davis et al., 2017) . The AOP-DB hosts 164,640 chemicals from CTD, with 846,574 gene-chemical associations.
In addition to chemical-gene associations, the AOP-DB includes direct relationships between AOPs and chemical stressors in the EPA's Distributed Structure-Searchable Toxicity (DSSTox) Database. DSSTox is a public resource that combines cheminformatics and toxicity data to aid in toxicology prediction and prioritization (Richard & Williams, 2002) . By returning a list of DSSTox chemical IDs that are associated with an AOP, the AOP-DB makes it possible to interface AOP predictions and associations with the power of EPA's iCSS Chemistry Dashboard (https://comptox.epa.gov/dashboard/). The AOP-DB hosts 22,038 chemicals from the DSSTox Database, with 188 confirmed DTX chemical-AOP associations mined directly from the AOP-Wiki, and approximately 30,000 inferred DTX chemical-AOP associations through CTD chemical-gene associations.
Disease
The associations between genes and human disease phenotypes in the AOP-DB are sourced from DisGeNET, which combines mined, curated, and inferred associations from ten sources for Mendelian, complex, environmental, and rare diseases as well as disease traits (Pinero et al., 2017) . Due to the redundancy of information across these ten data sources, a confidence score between 0 and 1 was calculated for each association based on the proportion of the sources that recognize that association. The AOP-DB contains 15,093 unique disease outcomes with 429,036 gene-disease associations.
Gene orthology
Cross-species homology describes genes in two or more taxa descended from a common ancestor. Functional orthologs retain the same protein functions as the ancestral gene (Gabaldon & Koonin, 2013) , allowing for the extrapolation of gene annotations across species based on ortholog concordance. In order to aid in the prediction of AOP susceptibility across different species, the AOP-DB includes orthology groupings from three sources: KEGG Orthology, NCBI HomoloGene, and the Meta-Phylogeny based Orthologs (metaPhOrs) database (Kanehisa et al., 2017; Pruitt & Maglott, 2001; Pryszcz, Huerta-Cepas, & Gabaldon, 2011) . KEGG Orthology groups orthologous genes and proteins by their molecular functions, while NCBI HomoloGene creates groups from a BLASTp similarity-constructed taxonomy tree. The AOP-DB contains 63,138 orthologous gene groups among 469 taxa. In contrast, metaPhOrs combines seven phylogenetic tree databases to make pairwise orthology predictions for 4.1 million proteins. Due to the redundancy of information across and among the constituent data sources, a confidence score in a given orthology prediction can be calculated based on proportion of sources also making that prediction. The AOP-DB contains 40.4 million pairwise orthology confidence scores among 1258 taxa.
Protein-protein interactions
The AOP-DB returns gene-gene interaction scores sourced from the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). The STRING database contains protein-protein interactions for over 2000 organisms, with each interaction scored by confidence level (Szklarczyk et al., 2015) . Interactions are sourced from experimental data from primary databases, computational prediction from highthroughput experiments and orthology extrapolation, and text mining. The AOP-DB hosts 443 million pairwise gene interaction scores for 665,746 unique genes.
M.E. Pittman et al. Toxicology and Applied Pharmacology 343 (2018) 71-83 2.1.8. Gene ontology The Gene Ontology Consortium provides a controlled, machinereadable vocabulary that enables computational analysis of functional annotation for genes (Ashburner et al., 2000; Gene Ontology, 2015) . In the AOP-DB, Entrez gene IDs are linked to their related GO biological process terms to help characterize the activity of a gene of interest. Currently, the AOP-DB contains 25,713 unique GO terms to describe the biological processes related to genes from 38 organisms.
ToxCast assays
The US Environmental Protection Agency's Toxicity ForeCaster (ToxCast™) program uses high-throughput in vitro assays to screen and prioritize chemicals for toxic effects (Dix et al., 2007; Judson et al., 2010) . The AOP-DB stores the ToxCast in vitro assay information for 942 chemical-endpoint pairs and includes information about chemicals, targets, assay types, activity concentrations, and other pertinent metadata for analysis. Through the AOP-DB's inferred associations, there are 432 ToxCast assays related to putative AOPs; these associations are fed to the EPA's Chemistry Dashboard to inform researchers of existing pathways and data related to a chemical of interest.
AOP-DB use case examples
Three use cases were chosen to demonstrate the utility of the AOP-DB: 1) characterizing the biological space of a putative AOP; 2) exploring the biological overlap between a collection of interconnected AOPs; and 3) hypothesis generation for the development of an AOP asyet-undefined by the OECD. Output was visualized using Cytoscape network visualization software (Shannon et al., 2003) .
3.1. Use case 1: characterization and accuracy of information "Androgen Receptor (AR) Agonism Leading to Reproductive Dysfunction" is a putative AOP endorsed by the Extended Advisory Group on Molecular Screening and Toxicogenomics (EAGMST), which oversees the development and assessment of AOPs (https://aopwiki. org/aops/23, Accessed 15 March 2017). To demonstrate the accuracy of the information contained in the database and to showcase its utility as a hypothesis-generation tool, queries were constructed to return the AR agonism gene targets and their associations in the AOP-DB to return the chemical lists, biological pathways, and diseases associated with ARagonism and its downstream effects. A flow diagram of this procedure is shown in Fig. 1. 
Use case 2: examining AOP context
Of interest is the linking of related AOPs via shared KEs, in order to provide a wider biological context for potential downstream effects of a given chemical stressor or biological perturbation. A series of AOPs linked through shared KEs make it possible to computationally form AOP networks, which can supplement the creation of expert-curated AOPs and improve our systems-level understanding of how toxicity pathways proceed (Knapen, Vergauwen, Villeneuve, & Ankley, 2015) . To explore the wider toxicological context of the AR agonism AOP, a group of related AOPs were selected by querying the AOP-DB for adverse outcomes involving "reproductive dysfunction." The AOP-DB stores the controlled vocabulary used to describe the objects, actions, processes, and contexts of an AOP's KEs, allowing users to automatically link AOPs in a network to examine their interactions. Results show the concordance and divergence between the reproductive dysfunction AOPs, identifying hub nodes (Events and Objects) that connect groups of closely-related reproductive toxicity pathways. A flow diagram for the examination and applications of putative AOP networks is shown in Fig. 3. 
Use case 3: potential AOP investigation and hypothesis generation
The AOP-DB may also be utilized to explore adverse outcomes that are not yet defined in the AOP framework. The AOP-DB can help to generate hypotheses for the identification of potential AOPs through a known outcome and its associated biological entities. The database was used to query associations across four diseases with closely-related gene associations (organophosphate poisoning, anxiety disorders, impaired cognition, and memory impairment), identify candidate KE genes, and explore the biological entities related to these candidate genes to characterize a potential AOP, "Acetylcholinesterase Inhibition Leading to Neuropsychological Dysfunction". Table 1 gives the enumeration and sources of entries for each information category in the database. The CTD chemical-gene associations, disease-gene associations, gene-gene interactions, and pairwise orthology scores are derived from secondary databases that combine Fig. 1 . Flowchart depicting the nature of potential lines of inquiry and their application. Queries constructed to examine the chemicals, diseases, functional processes, and species applicability of Key Event genes are applied to assay development and prioritization efforts.
Results
Database summary & quality checks
M.E. Pittman et al. Toxicology and Applied Pharmacology 343 (2018) 71-83 multiple sources, and in some cases calculate a confidence score. In addition to the datatype quality assurance methods built into the MySQL database creation and population procedure, we also queried the database to demonstrate that the AOP-DB returns expected results in accordance with the information in the AOP-Wiki. Some sample queries to this effect are shown in Supplemental Fig. 2 . We find that the AOP-DB returns sensible results across all tables, showing ACHE-related biological entities by following related threads from DSSTox chemical-AOP associations, CTD chemical-gene-AOP associations, and diseasegene-AOP associations. The pathways and ontology terms related to this AOP return items such as "Cholinergic synapse" pathways and "acetylcholinesterase activity" biological processes, which are implicitly related to acetylcholinesterase function.
Use Case 1: Exploring and verifying the biological activity of a putative AOP -Androgen receptor agonism leading to reproductive dysfunction (Aop:23).
In female teleost fish species, the AR agonism AOP occurs when a chemical stressor binds to the androgen receptor and causes reduced testosterone and estrogen synthesis in the ovarian theca cells, eventually leading to a decrease in production of vitellogenin (egg-yolk protein) by females (Villeneuve, 2017) . Established chemical initiators are comprised of non-aromatizable androgens, such as 17beta-trenbolone (Ankley et al., 2003) .
We have queried the AOP-DB to show that the information stored within is consistent with the established literature, and provides avenues for further investigation. From the AOP gene targets stored in the AOP-Wiki, we returned the chemical lists, biological pathways, and diseases associated with androgen receptor agonism and its downstream effects (Supplemental Table 1 ). We confirm that the established chemical stressor trenbolone (Villeneuve, 2017 ) is implicated in this AOP through gene-target associations and identify additional potential chemical stressors such as metribolone and mibolerone, known AR agonists (Luderschmidt, Jawny, & Eiermann, 1987) (Hammond et al., 2001) (Table 2 ). This demonstrates that information in the AOP-DB is consistent with known chemical stressors listed for an AOP, and suggests additional chemicals potentially worthy of assay development. Through the AOP-DB's gene orthology tables, we can examine which species and taxonomic divisions possess gene orthologs for the KE proteins necessary to the progression of the AOP (Fig. 2A) . For the AR agonism AOP, we see that vertebrate taxonomic groups across mammals, avians, reptiles, amphibians, and fish species all possess an ortholog for the AR; however, no invertebrate species were returned, suggesting that potential susceptibility of this AOP is limited to vertebrates.
By selecting KE genes, their closest gene interactions by confidence score, and the diseases most highly-associated with these genes, we can visually cluster the functional properties of an AOP. Fig. 2B shows the clustering of protein-protein interactions based on confidence scores for the AR agonism KE genes, and includes disease associations with those genes. Filtering based on phenotypic outcome of interest, like diseases involving infertility, can provide predictions about the potential activity of an MIE in a wider context, identifying additional genes that may affect the progression of the AOP, as well as genes that participate in similar AOPs (Fig. 2C) .
Use Case 2: Examining overlap of a group of inter-related AOPs (AOPs with the "reproductive dysfunction" Adverse Outcome). Fig. 4A shows the KE and KE Object relationships for just the AR agonism AOP. By linking fourteen reproductive AOPs via KEs and object interactions shared between AOPs, we expand this view and distinguish between four major classes of reproductive dysfunction pathway initiators in the AOP-Wiki: cyclooxygenase inhibition, hormone receptor interference, aromatase interference, and HIF-1α-related dysfunctions (Fig. 4B) . The aromatase, AR/ER, and HIF-1α AOP groups all converge upon the KE "Vitellogenin accumulation into oocytes and oocyte growth/development, Reduction" and its downstream effects. Cyclooxygenase AOPs, on the other hand, lead to hormonal disruptions with a host of adverse outcomes (such as altered mating behavior and failed meiotic assembly checkpoints).
Use Case 3: Generating hypotheses for predicted AOPs -AChE Inhibition leading to Neuropsychological Dysfunction.
Through casual exploration of disease links for proposed AOPs, we discovered that the gene targets involved in "Acetylcholinesterase (AChE) Inhibition Leading to Acute Mortality" (Russom, LaLone, Villeneuve, & Ankley, 2014) were also highly associated with negative neuropsychological effects, such as anxiety disorders (DisGeNET disease ID: umls:C0003469), impaired cognition (umls:C0338656), and memory impairment (umls:C0233794) (Fig. 6A) . Based on these associations, we predicted that AChE inhibition may also be associated with long-term neuropsychological dysfunction. In fact, this phenomenon is supported in the literature ) and is known as Chronic Organophosphate-Induced Neuropsychiatric Disorder (CO-PIND).
COPIND describes the group of co-occurring neuropsychological features that appear in occupational workers exposed to Table 2 An excerpt of query results for potentially-relevant chemicals to the androgen receptor agonism AOP.
MeSHID
ChemicalName Interaction C003600 11-ketotestosterone 11-ketotestosterone binds to and results in increased activity of AR protein C026486 1,2,5,6-dibenzanthracene 1,2,5,6-dibenzanthracene binds to and results in increased activity of AR protein C517232 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane binds to and results in increased activity of AR protein C010422 2,4,6-trichlorophenyl 4-nitrophenyl ether 2,4,6-trichlorophenyl 4-nitrophenyl ether binds to and results in increased activity of AR protein C003524 4,16-androstadien-3-one 4,16-androstadien-3-one analog binds to and results in increased activity of AR protein The three large clusters represent the taxa whose AOPWiki object IDs were associated with the AR gene identifier (in yellow): Human, Mouse, and Rat. Genes that are highly associated with AR (shown in blue) are clustered based on interaction confidence score. The human cluster (bottom) also shows gene-disease relationships for these closely-associated genes, with diseases represented by purple nodes. 2C: A subset of Network 2B, showing the genes that were both highly associated with the AR gene AND highly associated with the diseases "Female infertility" and "Male infertility". (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
M.E. Pittman et al. Toxicology and Applied Pharmacology 343 (2018) 71-83 organophosphate pesticides, such as farm and ranch workers . Whereas initial symptoms of acute organophosphate poisoning include neurophysiological effects like muscle paralysis and ataxia, follow-up studies of affected individuals have revealed behavioral changes including confusion, anxiety, depression, and problems with memory and concentration (Arun & Palimar, 2005) . These symptoms persist for years after the reported initial exposures (Davies, Mrcpsych, Ahmed, & Freer, 2009; Institute of Medicine, 2000) . Increased hippocampal ACh signaling in the brain and ACHE knockdown in the hippocampus lead to depression-like behaviors in mice, suggesting that ACHE inhibition (and the resulting accumulation of acetylcholine) could be the cause of these behaviors in individuals exposed to ACHE inhibitors (Mineur et al., 2013) . We selected genes that were shared between organophosphate poisoning and any of the other three examined disease outcomes. These genes are considered candidate Objects of a molecular KE (Table 3) . From these candidate genes, we queried the AOP-DB to characterize the biological space of their collective activity, finding 66 pathways in which they participate (Fig. 6B) . These pathways can be examined for links to the disease outcomes of interest, such as the anti-inflammatory NRF2 pathway that has been implicated in Major Depressive Disorder (Martín-de-Saavedra et al., 2013) . Thus, the AOP-DB can suggest avenues of AOP progression through the linkage of MIEs to functional pathways. We also examine the orthology of the candidate genes, finding that ACHE and BCHE are likely paralogs, as well as GSTM1 and GSTP1, as each pair is closely phylogenetically linked (Supplemental Fig. 3 ). We also find that all candidate genes show some level of relatedness to a wide variety of taxa, including invertebrates and fungi. However, the Adverse Outcome of neuropsychological dysfunction is implicitly limited to animal species for which behavior disturbance can be measured.
Discussion
We have presented the AOP-DB, a database resource that collects and connects public annotation information for chemicals, diseases, proteins, pathways, and their interactions through gene IDs to associate them with putative Adverse Outcome Pathways. The AOP-DB mines AOP-gene associations from the AOP-Wiki in a direct and automated fashion, allowing for the instantaneous integration of all available information for putative AOPs as they are developed. Important AOP associations, such as ToxCast assays relevant to putative AOPs and DSSTox chemical entries identified as AOP stressors, are then fed into other EPA computational toxicology tools to interface between AOP Discovery and Development efforts and existing data. Through queries constructed to follow entity-relationships across multiple tables, we confirm that the database returns consistent results for the characterization of the activity and context of putative AOPs (Supplemental Fig. 2, Fig. 2) .
We predict that the data association types contained in the AOP-DB will be useful for researchers exploring the wider biological context of an AOP, for instance by: 1) providing expanded lists of genes potentially impacted by a given chemical stressor; 2) providing lists of genes that interact strongly with an AOP's KE genes; 3) specifying potential disease outcomes of perturbations on KE genes, or genes of interest discovered through (1) and (2); 4) the intersection between an AOP of interest and all other putative AOPs defined in the AOP-Wiki, defined by shared KEs and Objects.
Based on MIEs tagged in the AOP-Wiki, chemical-gene associations can be used to identify groups of chemicals that might initiate a given AOP or expand a list of potential stressors, as with our first case study in which we identified the potential chemical stressors like mibolerone and metribolone, non-aromatizable androgens similar in structure to the established chemical stressor trenbolone (Table 2) . Because the AOP-DB is focused on chemicals relevant to environmental toxicity, the database is especially useful for generating hypotheses regarding the action and impact of environmental chemical stressors.
Disease-gene associations can be used to recognize possible outcomes of perturbations on specific genes to generate hypotheses for potential AOPs, as with our case study predicting a potential AOP with the MIE "Acetylcholinesterase inhibition" and the AO "Neuropsychological dysfunction" (Fig. 6B) . Through exploration of the Fig. 3 . Flowchart depicting the series of inquiries made to the AOP-DB (blue elements) to characterize the concordance and divergence between groups of AOPs (green elements). Additionally, the AOP-DB can be used in meta-analysis of the AOP-Wiki (orange elements). For example, the AOP-DB might discover (via AOP-KE-Object connections) that one AOP categorized in the Wiki has included intermediate steps between two events, while another related AOP has not included these steps. The AOP-Wiki can then be edited to resolve this inconsistency. The AOP-DB can also be used to predict new AOPs, for example if a previously unidentified Molecular Initiating Event (MIE) is known to activate a KE already in the Wiki. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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M.E. Pittman et al. Toxicology and Applied Pharmacology 343 (2018) 71-83 pathways linked to the disease-associated genes and confirmation through literature search, we named and identified the candidate KE "increased concentration of acetylcholine in the hippocampus," leading to "increase in anxiety and depression-like symptoms." Besides depression and anxiety, two organophosphate-related diseases were memory and cognitive impairment; however, we find that these sequelae require more evidence, or should perhaps comprise a separate adverse outcome, as we found no literature to support acetylcholine accumulation in the hippocampus directly leading to memory and cognitive dysfunction. Thus we show the AOP-DB's utility in proposing potential AOPs, predicting constituent KEs, and identifying knowledge gaps that would benefit from additional research. For a selected putative or computationally-predicted AOP, the AOP-DB can return a list of species that possess orthologs for all or some of those genes ( Fig. 2A) . Use of such a result can provide a preliminary prediction for taxonomic applicability (e.g. if a taxonomic group lacks a functional ortholog for a gene that is fundamental to the progression of the MIE or downstream KEs, we then have information that these species are not at risk for that particular AOP, informing chemical prioritization). In addition, consistency scores for orthology predictions can give a measure of confidence that a given gene pair is a functional ortholog. Thus, the AOP-DB has the capability to illustrate, for a given list of genes, which species are predicted to have orthologs for these genes, and with what confidence. This feature makes the AOP-DB a useful tool for defining a range of taxonomic applicability for an AOP. Currently, the AOP-DB's AOP-gene, gene-pathway, and gene-orthology relationships are being combined to examine and compare the systemslevel activity of AOP-related genes across organisms as part of a computational workflow to define taxonomic applicability for AOPs (Mortensen, Pittman et al. in prep) . Note, however, that the confidence scores for orthology prediction are derived from consistency of annotation across several sources and not on physical similarity; therefore, some members of more-closely related taxonomic groups may show lower confidence scores than more distantly-related groups (see Supplemental Fig. 3 for examples of this phenomenon). In the future, we hope to include measures of protein similarity instead of annotation consistency.
The ontology terms tagged in the AOPwiki and stored in the AOP-DB can link a group of interrelated AOPs by shared KEs and objects, expanding predictive toxicity models and supporting the development of related AOPs. Reproductive dysfunction networks have been previously investigated by (Knapen et al. (2015) ), in which multiple AOPs were linked via altered vitellogenin (egg-yolk protein) mRNA expression. Our AOP network constructed from the putative reproductive dysfunction AOPs is consistent with their finding that aromatase and AR/ER interference converge upon altered vitellogenin production; our methods also include HIF-1α AOPs in this group, as well as a separate class of reproductive AOPs initiated by Cyclooxygenase inhibition (Fig. 4B) . While previous methods used information curated manually from the AOP-Wiki, the AOP-DB allows for fast, automatic creation of these networks, thus dramatically expediting such efforts to aid in predictive toxicology.
The AOP-DB is uniquely useful as a single integrated source of biological information that is interconnected with AOP knowledge. We foresee the AOP-DB being used by researchers to elaborate upon their chemical and gene target hypotheses using association tables, or to elucidate mechanisms through pathway, gene interaction, and KE information tables. However, many of the AOP-DB association tables cover a substantial amount of experimental and secondary association data, which can lead to the return of spurious results. Though confidence scores can provide a primary filter, this strategy comes with caveats. Confidence scores, for example those leveraged by the geneorthology, gene-disease, and gene-interaction associations, do not necessarily coincide with AOP-relevance. For AOPs that are not wellcharacterized in the scientific literature, associations may be mentioned by few sources, and thus return a relatively low confidence score compared to well-studied associations. While network computational analysis would be an interesting avenue to explore in the AOP-DB, Fig. 4 . Visual diagrams to show the relationships between AOPs, constituent KEs, and the objects upon which they act. 4A: KE and object relationships for the AR agonism AOP alone. 4B: KE and object relationships for all "Reproductive Dysfunction" AOPs. The red circles enclose the two major classes of reproductive dysfunction AOPs: Cyclooxygenase Inhibition AOPs (left), and altered Vitellogenin (VTG) production AOPs (right). Within the altered VTG class, there are three sub-classes of AOP types: those resulting from alteration in hormone receptor activity, those stemming from aromatase inhibition, and those resulting from an increase in HIF-1α concentration (demarcated by blue circles). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Fig. 5 . Flowchart depicting the series of steps taken to develop a predicted AOP from the AOP-DB.
M.E. Pittman et al. Toxicology and Applied Pharmacology 343 (2018) 71-83 prioritized ranking based on confidence scores alone would not necessarily converge with the biological evidence supporting an AOP of interest. Therefore, at present we recommend that AOP-DB analyses be accompanied by the interpretation of skilled toxicologists and biologists to identify likely candidates for further pathway exploration and to assess the implications of AOP relationships. The AOP-DB can therefore be considered as an AOP profiling and exploration tool that gives a broad, systems-level overview of the context in which putative AOPs operate. The AOP-DB simplifies the creation of network visualizations, using data points as nodes and association scores as edges, which will help researchers view and understand the action of KEs not only in the systems context of general biology, but also in the context of existing AOP vocabulary. Since one of the goals of the AOP structure is to use standardized language with a reusable "building block" philosophy for KEs and their relationships, the AOP-DB is especially suited for proposing new AOPs related to existing entries.
Another caveat is that the AOP-DB stores the information found in its constituent sources without skepticism or alteration. Though we have ensured that all the sources from which the AOP-DB draws its information use robust and peer-reviewed methods, the false positives and false negatives native to these sources are transferred to the AOP-DB. However, we predict that our use of multiple sources for certain datatypes may offset some false negatives.
Finally, the relationships between AOPs and their KEs, objects, and chemical stressors are limited to those that have been defined in the AOP-Wiki. Some entries are still under development and may be subject to change before formal endorsement. These gaps and uncertainties will be resolved as the AOP-KB grows and matures, but in the meantime it should be noted that AOP discovery and development is in its preliminary stages, and by extension the information contained in the AOP-DB is under development.
In summary, the AOP-DB provides an interface between chemical prioritization efforts and the AOP-KB, and automatically integrates large-scale gene association data for the characterization of putative and predicted AOPs in a variety of contexts. Since the AOP-DB is standardized by gene linkages, future integration of new data sources and types is as simple as finding Entrez gene associations with the relevant data points. Because the AOP-DB leverages gene-gene association scores to cluster gene lists by confidence-of-interaction level, one future use could be to computationally prioritize related gene interactions, and thus predict the downstream molecular effects of an MIE binding. Another potential use of the AOP-DB is to screen putative AOPs for disease and chemical association in order to characterize human population level genetic susceptibility (Mortensen, Chamberlin, et al. in prep) , which directly contributes to the EPAs explicit consideration of vulnerable populations as laid out in the Frank R. Lautenberg Chemical Safety for the 21st Century Act to reform the Toxic Substances Control Act.
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